Corline Biomedical
Logotype for Corline Biomedical

Corline Biomedical (CLBIO) investor relations material

Corline Biomedical Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Corline Biomedical
Q4 2025 earnings summary17 Feb, 2026

Executive summary

  • Achieved key milestone with first commercial use of CHS™ in a US-launched product, driving entry into the fast-growing PFA market for cardiac arrhythmia treatment.

  • Strategic focus on scaling production and strengthening partnerships, notably with Kardium, to support anticipated volume growth and customer activity in 2026.

Financial highlights

  • Net sales for Q4 2025 were 2,104 KSEK, up slightly from 2,012 KSEK in Q4 2024; full-year net sales were 7,651 KSEK, down from 9,775 KSEK year-over-year.

  • Q4 result after financial items was -5,027 KSEK (improved from -14,161 KSEK); full-year result after financial items was -14,714 KSEK (improved from -23,194 KSEK).

  • No one-time items affected 2025 results, compared to -9,992 KSEK in 2024.

  • Cash and cash equivalents at year-end were 20.6 MSEK, up from 17.7 MSEK.

  • Equity at year-end was 93,759 KSEK, with a solidity of 95%.

Outlook and guidance

  • Expecting volume growth and increased customer activity in 2026, supported by commercial agreements and regulatory tailwinds in the US.

  • Ongoing investments in production capacity and quality systems to meet future demand and regulatory requirements.

What revenue impact from 20x Kardium volume?
CHS™ Growth: US medtech customer pipeline
How does Globe's PFA differentiation impact Corline?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Corline Biomedical earnings date

Logotype for Corline Biomedical
Q1 20268 May, 2026
Corline Biomedical
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Corline Biomedical earnings date

Logotype for Corline Biomedical
Q1 20268 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Corline Biomedical AB is a Swedish biotechnology company focused on developing heparin-based medical solutions to improve outcomes in kidney transplantation and cell therapies. The company’s proprietary Corline Heparin Conjugate (CHC) technology is central to its product offerings. Key products include Renaparin, aimed at improving kidney transplantation by reducing complications during surgery, and Cytoparin, designed for cell therapy applications, particularly in the treatment of type 1 diabetes. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Stockholm Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage